We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy

    Background

    No study has comparing hepatitis B virus (HBV) relapse rates among patients with both cancer and hepatitis B e antigen (HBeAg)-negative...

    Hsin-Wei Fang, Po-Lin Tseng, ... Chien-Hung Chen in Virology Journal
    Article Open access 03 April 2024
  2. PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation

    There is an increased risk of GVHD and of non-relapse mortality (NRM) after allogeneic stem cell transplantations (alloSCT) when mismatched unrelated...

    Olaf Penack, Mouad Abouqateb, ... Zinaida Peric in Blood Cancer Journal
    Article Open access 15 March 2024
  3. Norfloxacin prophylaxis effect on multidrug resistance in patients with cirrhosis and bacterial infections

    It is unclear whether norfloxacin predisposes to infections by multidrug-resistant organisms (MDROs). We aimed to evaluate if patients with...

    Sebastián Marciano, Maria N. Gutierrez-Acevedo, ... Diego H. Giunta in European Journal of Clinical Microbiology & Infectious Diseases
    Article 23 February 2023
  4. Letermovir for CMV Prophylaxis in Very High-Risk Pediatric Hematopoietic Stem Cell Transplantation Recipients for Inborn Errors of Immunity

    The burden of CMV infection and disease is important in pediatric hematopoietic stem cell transplantation (HSCT), notably in the subgroup of patients...

    Thibaut César, Minh P. Le, ... Bénédicte Neven in Journal of Clinical Immunology
    Article 20 December 2023
  5. Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel

    Bispecific antibodies (BsAbs) are emerging as an important novel class of immunotherapeutic agents for the treatment of multiple myeloma (MM), and...

    Noopur Raje, Kenneth Anderson, ... Maria-Victoria Mateos in Blood Cancer Journal
    Article Open access 01 August 2023
  6. Impact of antibiotic prophylaxis in second-stage surgery in joint prosthesis infection treated with two-stage exchange. A multicenter case–control study

    Introduction

    After two-stage exchange due to prosthetic joint infection (PJI), the new prosthesis carries a high risk of reinfection (RePJI). There...

    Jose M. Barbero Allende, Encarnación Fernández Antón, ... Francisco José de Abajo Iglesias in European Journal of Clinical Microbiology & Infectious Diseases
    Article 15 May 2024
  7. Impact of posaconazole prophylaxis and antifungal treatment on BAL GM performance in hematology malignancy patients with febrile neutropenia: a real life experience

    Background

    Diagnostic accuracy of galactomannan measurements is highly variable depending on the study population, diagnostic procedures, and...

    Nilüfer Aylin Acet-Öztürk, Dilara Ömer-Topçu, ... Halis Akalın in European Journal of Clinical Microbiology & Infectious Diseases
    Article 01 November 2023
  8. A case of successful contribution of therapeutic drug monitoring of valganciclovir as the prophylaxis against cytomegalovirus infection in a lung transplant recipient

    Background

    Ganciclovir and its prodrug, valganciclovir, are first-line agents for cytomegalovirus infection prophylaxis after lung transplantation....

    Yoshiki Katada, Keisuke Umemura, ... Tomohiro Terada in Journal of Pharmaceutical Health Care and Sciences
    Article Open access 07 June 2024
  9. Messenger RNA for Prophylaxis

    Remarkable advances in mRNA and ionizable lipid-based carrier innovations have allowed the unprecedented speed of development for these technologies...
    Nicholas Jackson in Messenger RNA Therapeutics
    Chapter 2022
  10. Association of antimicrobial perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in colorectal surgery

    Objective

    To compare intravenous (IV) amoxicillin/clavulanic acid (A/CA) to IV cefuroxime plus metronidazole (C + M) for preventing surgical site...

    Elisavet Stavropoulou, Andrew Atkinson, ... Nicolas Troillet in Antimicrobial Resistance & Infection Control
    Article Open access 19 September 2023
  11. Association between perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in paediatric uncomplicated appendectomy: a Swiss retrospective cohort study

    Objective

    We aimed to evaluate the association between post-appendectomy SSI rates and the two most commonly used regimens for perioperative...

    Isabella Bielicki, Hanna Schmid, ... Walter Zingg in Antimicrobial Resistance & Infection Control
    Article Open access 25 September 2023
  12. Community engagement among forest goers in a malaria prophylaxis trial: implementation challenges and implications

    Background

    Malaria transmission in Southeast Asia is increasingly confined to forests, where marginalized groups are exposed primarily through their...

    Franca Conradis-Jansen, Rupam Tripura, ... Richard J. Maude in Malaria Journal
    Article Open access 08 June 2023
  13. The evaluation of atorvastatin as an adjunct to fluconazole for the anti-fungal prophylaxis in acute myeloid leukemia: a multicenter, triple-blinded, randomized clinical trial

    The development of invasive fungal infections (IFIs) is a serious complication in acute myeloid leukemia (AML) patients who undergo an induction to...

    Niloufar Saber-Moghaddam, Mohammad Moeini Nodeh, ... Omid Arasteh in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 14 December 2023
  14. Population pharmacokinetic analysis of lopinavir in HIV negative individuals exposed to SARS-CoV-2: a COPEP (COronavirus Post-Exposure Prophylaxis) sub-study

    Background

    Lopinavir/ritonavir (LPV/r) is a drug traditionally used for the treatment of HIV that has been repurposed as a potential post-exposure...

    Paul Thoueille, Margot Delfraysse, ... Monia Guidi in BMC Pharmacology and Toxicology
    Article Open access 27 September 2023
  15. Model-based predictions of protective HIV pre-exposure prophylaxis adherence levels in cisgender women

    Most human immunodeficiency virus (HIV) infections occur in cisgender women in resource-limited settings. In women, self-protection with...

    Lanxin Zhang, Sara Iannuzzi, ... Max von Kleist in Nature Medicine
    Article Open access 13 November 2023
  16. Antibiotic prophylaxis with piperacillin–tazobactam reduces organ/space surgical site infection after pancreaticoduodenectomy: a retrospective and propensity score-matched analysis

    Background

    The occurrence of surgical site infection (SSI) after pancreaticoduodenectomy (PD) is still relatively high. The aim of this retrospective...

    Yifei Yang, Jianjie Sheng, ... Xu Fu in BMC Cancer
    Article Open access 23 February 2024
  17. Non-invasive brain stimulation treatments for migraine prophylaxis: a network meta-analysis of randomized controlled trials

    Background and objectives

    Migraine is a major public health problem owing to its long disease duration and disease relapse. Non-invasive brain...

    Yi-Lin Chen, Qian Chen, ... Hui Zheng in Acta Neurologica Belgica
    Article 15 May 2023
  18. Efficacy estimates of oral pre-exposure prophylaxis for HIV prevention in cisgender women with partial adherence

    Pre-exposure prophylaxis (PrEP) with tenofovir (TFV) disoproxil fumarate and emtricitabine administered orally daily is effective in preventing human...

    Mia Moore, Sarah Stansfield, ... Dobromir Dimitrov in Nature Medicine
    Article 05 October 2023
  19. Therapeutic failures of targeted antibiotic prophylaxis in urology

    Targeted antibiotic prophylaxis (TAP) is required for patients with positive urine culture before urological surgery. Our aim was to determine the...

    Elodie Curlier, Yvanne Sadreux, ... Pierre-Marie Roger in European Journal of Clinical Microbiology & Infectious Diseases
    Article 17 November 2021
  20. The transition from transrectal to transperineal prostate biopsy without antibiotic prophylaxis: Cancer detection rates and complication rates

    Background

    Currently, transperineal prostate biopsy (TPB) is preferred over transrectal biopsy (TRB) because of less infectious complications and...

    Renée Hogenhout, Sebastiaan Remmers, ... Monique J. Roobol in Prostate Cancer and Prostatic Diseases
    Article 11 January 2023
Did you find what you were looking for? Share feedback.